Key result
Diabetic platelets lack enhanced adhesion under flow conditions but express lower GPIIIa.
Why the study?
Little evidence exists regarding whether blood platelets from individuals with atherosclerosis-associated conditions have higher adhesion potential under flow conditions or how diabetes affects GPIIIa.
Does diabetes alter the adhesion potential and GPIIIa expression of blood platelets under in vitro flow conditions?
Population
Blood platelets from diabetic and non-diabetic humans
Comparison
Diabetic patients vs non-diabetic humans
Design
In vitro comparative study
Authors
Loading...
Platelet adhesion under flow appears unaltered in diabetes; leaves open endothelial dysfunction as primary driver for further study.
Observational
Does diabetes alter the adhesion potential and GPIIIa expression of blood platelets under in vitro flow conditions?
Diabetes alters platelet functionality by increasing basal activation and decreasing GPIIIa expression, but this does not inherently increase their adhesive potential under flow conditions, suggesting that vascular wall dysfunction may primarily drive increased platelet-endothelium interactions in diabetes.
Przygodzki et al. (2020) conducted an observational in Diabetes. Diabetes vs. Non-diabetic humans was evaluated on Platelet adhesion to fibrinogen and von Willebrand factor under flow conditions. Blood platelets from diabetic patients did not demonstrate enhanced adhesion to fibrinogen or von Willebrand factor under flow conditions, but showed lower expression of GPIIIa.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: